You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 25, 2025

Patent: 10,017,492


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,017,492
Title:Isoindoline derivative, intermediate, preparation method, pharmaceutical composition and use thereof
Abstract: Provided are an isoindoline derivative, intermediate, preparation method, pharmaceutical composition and use thereof. The isoindoline derivative and the pharmaceutical composition thereof can regulate the production or activity of immunological cytokines, thus effectively treating cancer and inflammatory disease. ##STR00001##
Inventor(s): Ge; Chuansheng (Shanghai, CN), Lee; Wen-Cherng (Shanghai, CN), Liao; Baisong (Shanghai, CN), Zhang; Lei (Shanghai, CN)
Assignee: KANGPU BIOPHARMACEUTICALS, LTD. (Shanghai, CN)
Application Number:15/523,651
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Understanding the Patent Landscape: A Comprehensive Analysis of US Patent 10,017,492

Introduction

Patent law and the process of obtaining a patent in the United States are complex and multifaceted. This article will delve into the specifics of US Patent 10,017,492, analyzing its claims, the broader patent landscape, and the critical factors influencing patent eligibility and enforcement.

Patent 10,017,492: Overview

To begin, it is essential to understand the basic details of the patent in question. US Patent 10,017,492 would typically include information such as the inventors, the assignee, the filing and grant dates, and a detailed description of the invention along with its claims.

Claims Analysis

Types of Claims

Patent claims are the heart of any patent application, defining the scope of the invention for which protection is sought. Claims can be categorized into independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[4].

Claim Construction and Interpretation

The construction and interpretation of claims are crucial for determining the patent's scope and validity. Claims must be clear, concise, and definite to avoid ambiguity. The courts have established precedents, such as the case of Festo Corporation v. Shoketsu Kinzoku Kogyo Kabushiki Co. Ltd., which highlight the importance of claim amendments during prosecution and their impact on the doctrine of equivalents and prosecution history estoppel[5].

Subject Matter Eligibility

A critical aspect of patent claims is their subject matter eligibility. The USPTO and courts apply the Alice test to determine if claims are directed to abstract ideas, laws of nature, or natural phenomena. For a claim to be patent-eligible, it must integrate a judicial exception into a practical application, providing a meaningful limit that transforms the abstract idea into patent-eligible subject matter[3].

The Alice Test and Its Implications

Abstract Ideas

The Alice test, established by the Supreme Court, involves two steps: determining if the claim is directed to an abstract idea, and if so, assessing whether the claim elements, both individually and as an ordered combination, add enough to transform the nature of the claim into a patent-eligible application. The case of Electric Power Group, LLC v. Alstom S.A. illustrates how claims that merely collect, analyze, and display data without a concrete technological improvement can fail this test[2].

Practical Application

The 2024 USPTO guidance update on AI patents emphasizes the importance of demonstrating real-world applications of the claimed method or system. Claims must specify how the abstract idea is applied in a way that provides concrete benefits or solves specific problems in the relevant field. For example, a claim that uses separated audio components in a real-time speech recognition system to enhance voice command accuracy is considered patent-eligible because it integrates the abstract idea into a practical application[3].

Continuation Procedures and Their Impact

Types of Continuations

Patent applications can undergo various continuation procedures, including Requests for Continued Examination (RCEs), continuations-in-part (CIPs), and divisional applications. These procedures can significantly impact the calculation of patent allowance rates and the overall patent landscape. For instance, RCEs allow applicants to continue the examination process multiple times, while CIPs permit the introduction of new subject matter[1].

Allowance Rates

The probability of receiving a US patent is influenced by several factors, including the type of continuation procedures used. The USPTO calculates different allowance rates, such as the first-action allowance rate, progenitor allowance rate, and family allowance rate, to account for the complexities of the examination process. These rates help in understanding the likelihood of a patent application being granted, including the outcomes of continuation applications[1].

Advanced Patent Searching Techniques

Importance of Comprehensive Searches

Conducting a thorough patent search is essential for researchers, legal teams, and businesses. This involves going beyond basic searches to include variations in claims across related patents within a patent family. Claims can be amended or narrowed during the prosecution process, affecting the scope of protection[4].

Automated Tools

Given the increasing complexity and volume of patent claims, automated tools and systems are becoming more necessary. These tools can help in importing and analyzing patent claims, reducing the amount of information users need to review to make judgments about the claims[5].

Real-World Applications and Benefits

Demonstrating Practical Utility

To ensure patent eligibility, it is crucial to highlight the real-world applications and benefits of the claimed invention. This involves showing how the invention solves specific problems or provides concrete benefits in the relevant field. For example, a claim that improves the accuracy of speech recognition systems by using separated audio components in a hands-free environment demonstrates a tangible outcome that directly benefits the technology[3].

Industry Impact

Patents like US Patent 10,017,492 can have significant impacts on their respective industries. By protecting innovative solutions, patents encourage investment in research and development, drive technological advancement, and provide a competitive edge to the patent holders.

Key Takeaways

  • Subject Matter Eligibility: Claims must integrate abstract ideas into practical applications to be patent-eligible.
  • Claim Construction: Clear and concise claims are essential for avoiding ambiguity and ensuring the patent's scope is well-defined.
  • Continuation Procedures: These procedures can significantly affect the patent allowance rates and the overall patent landscape.
  • Advanced Searches: Comprehensive patent searches are critical for understanding the patent landscape and avoiding potential infringements.
  • Real-World Applications: Demonstrating practical utility and real-world benefits is crucial for patent eligibility and industry impact.

FAQs

What is the Alice test, and how does it impact patent claims?

The Alice test is a two-step process used to determine if a patent claim is directed to an abstract idea and if it adds enough to transform the nature of the claim into a patent-eligible application. It significantly impacts patent claims by requiring them to integrate abstract ideas into practical applications.

How do continuation procedures affect patent allowance rates?

Continuation procedures, such as RCEs and CIPs, can affect patent allowance rates by allowing applicants to continue the examination process, potentially leading to multiple patents from a single progenitor application.

Why is it important to conduct comprehensive patent searches?

Comprehensive patent searches are important because they help in identifying variations in claims across related patents, avoiding potential infringements, and understanding the broader patent landscape.

How does the 2024 USPTO guidance update impact AI-related patents?

The 2024 USPTO guidance update refines the process for determining the patent eligibility of AI-related inventions by providing detailed eligibility analysis and examples. It emphasizes the integration of judicial exceptions into practical applications and ensures AI-assisted inventions are evaluated on equal footing with other technologies.

What role do automated tools play in patent claim analysis?

Automated tools help in importing and analyzing patent claims, reducing the amount of information users need to review. This is particularly useful given the increasing complexity and volume of patent claims.

Sources

  1. Carley, M., & Hegde, D. (n.d.). What Is the Probability of Receiving a US Patent?. Retrieved from https://yjolt.org/sites/default/files/carley_hegde_marco-what_is_the_probability_of_receiving_a_us_patent_0.pdf
  2. Electric Power Group, LLC v. Alstom S.A. (2016, July 28). Retrieved from https://cafc.uscourts.gov/opinions-orders/15-1778.opinion.7-28-2016.1.pdf
  3. Mintz. (2024, July 25). Understanding the 2024 USPTO Guidance Update on AI Patent. Retrieved from https://www.mintz.com/insights-center/viewpoints/2231/2024-07-24-understanding-2024-uspto-guidance-update-ai-patent
  4. CAS. (2023, July 24). Advanced patent searching techniques - CAS.org. Retrieved from https://www.cas.org/resources/cas-insights/patent-searching-going-beyond-basics-increase
  5. Google Patents. (n.d.). US20110138338A1 - Patent Claims Analysis System and Method. Retrieved from https://patents.google.com/patent/US20110138338A1/en

More… ↓

⤷  Try for Free

Details for Patent 10,017,492

ApplicantTradenameBiologic IngredientDosage FormBLAApproval DatePatent No.Expiredate
Genentech, Inc. RITUXAN rituximab Injection 103705 November 26, 1997 ⤷  Try for Free 2034-10-30
Genentech, Inc. HERCEPTIN trastuzumab For Injection 103792 September 25, 1998 ⤷  Try for Free 2034-10-30
Genentech, Inc. HERCEPTIN trastuzumab For Injection 103792 February 10, 2017 ⤷  Try for Free 2034-10-30
>Applicant>Tradename>Biologic Ingredient>Dosage Form>BLA>Approval Date>Patent No.>Expiredate
Showing 1 to 3 of 3 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.